Gulati R, Bailey R, Prentice A M, Brabin B J, Owens S
Child and Reproductive Health Group, Liverpool School of Tropical Medicine, Liverpool, UK.
Eur J Clin Nutr. 2009 Aug;63(8):970-7. doi: 10.1038/ejcn.2009.11. Epub 2009 Mar 4.
BACKGROUND/OBJECTIVES: The use of multimicronutrient (MMN) supplementation to reduce the burden of anaemia in non-pregnant women of reproductive age has been little studied, particularly in Africa. The objective of the study was to evaluate haematological outcomes in non-pregnant, rural Gambian women of reproductive age, receiving daily MMN supplements for 1 year.
SUBJECTS/METHODS: The study in 293 women aged from 17 to 45 years old was nested within a double-blind, randomized placebo-controlled trial of periconceptional MMN supplementation [ISRCTN 13687662], using the United Nations International Multiple Micronutrient Preparation (UNIMMAP), received daily for 1 year or until conception. Red cell parameters and free erythrocyte protoporphyrin concentration were measured at baseline and after 12 months in those women who did not conceive.
Anaemic women (haemoglobin concentration <12 g per 100 ml) were more likely to be older and in economic deficit at baseline. Mean change in haemoglobin concentration was +0.6+/-1.4 g per 100 ml in the intervention arm and -0.2+/-1.2 g per 100 ml in the placebo arm (P<0.001). After supplementation with MMN, the relative risk of anaemia (<12 g per 100 ml) was 0.59 (0.46, 0.76) compared with placebo. Anaemic subjects at baseline showed an increase in mean haemoglobin from 10.6 g per 100 ml to 11.8 g/l (P<0.001) after MMN supplementation.
MMN supplementation should be considered as a strategy for improving the micronutrient and haematological status of non-pregnant women of reproductive age.
背景/目的:使用多种微量营养素(MMN)补充剂来减轻育龄非孕妇女贫血负担的研究较少,尤其是在非洲。本研究的目的是评估在冈比亚农村地区,每日接受MMN补充剂1年的育龄非孕妇女的血液学指标变化。
对象/方法:该研究纳入了293名年龄在17至45岁之间的妇女,嵌套于一项关于孕期前MMN补充剂的双盲、随机、安慰剂对照试验[国际标准随机对照试验编号13687662]中,使用联合国国际多种微量营养素制剂(UNIMMAP),每日服用,为期1年或直至怀孕。未怀孕的妇女在基线和12个月后测量红细胞参数和游离红细胞原卟啉浓度。
贫血妇女(血红蛋白浓度<12g/100ml)在基线时年龄较大且经济状况较差。干预组血红蛋白浓度的平均变化为+0.6±1.4g/100ml,安慰剂组为-0.2±1.2g/100ml(P<0.001)。补充MMN后,贫血(<12g/100ml)的相对风险与安慰剂相比为0.59(0.46,0.76)。基线时贫血的受试者在补充MMN后,平均血红蛋白从10.6g/100ml增加到11.8g/l(P<0.001)。
应考虑将补充MMN作为改善育龄非孕妇女微量营养素和血液学状况的一种策略。